(4S,5R)-5-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)-3-((4'-FLUORO-2'-HYDROXY-5'-(1-HYDROXY-1-METHYLETHYL)-4-(TRIFLUOROMETHYL)(1,1'-BIPHENYL)-2-YL)METHYL)-4-METHYL-2-OXAZOLIDINONE
UNII LJ3ZB1DZD7
Substance Identification & Data
This profile provides standardized clinical and technical data for (4s,5r)-5-(3,5-bis(trifluoromethyl)phenyl)-3-((4'-fluoro-2'-hydroxy-5'-(1-hydroxy-1-methylethyl)-4-(trifluoromethyl)(1,1'-biphenyl)-2-yl)methyl)-4-methyl-2-oxazolidinone, uniquely identified by the FDA Unique Ingredient Identifier (UNII) LJ3ZB1DZD7.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1865729-62-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C29H23F10NO4 RSQFGFDCARCMTE-RZFZLAGVSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (4s,5r)-5-(3,5-bis(trifluoromethyl)phenyl)-3-((4'-fluoro-2'-hydroxy-5'-(1-hydroxy-1-methylethyl)-4-(trifluoromethyl)(1,1'-biphenyl)-2-yl)methyl)-4-methyl-2-oxazolidinone. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.